In this period marked by a real emergency for collective health following the worldwide spread of Covid-19 (so-called “coronavirus“), it is essential to ensure Italy the know-how necessary for scientific research, exploiting the best elements among researchers and scientists currently residing abroad, thus enhancing the return of brains and the search for an effective vaccine. In particular, multinational companies operating in the biotech, pharmaceutical and scientific research sectors are currently managing the international mobility of…